INS and type 1 diabetes mellitus: A possible implication of this finding could be a lower insulin requirement in overweight patients and this would benefit Tanzanian T1DM patients who have been reported to “reduce the prescribed insulin dose in order to guarantee a longer period of treatment.”9 Insulin regime used was significantly associated with HbA1c since those participants who were using actrapid and insulatard in separate injections (n = 144) had an HbA1c of 12.3 ± 2.2% whilst those using other insulin combinations (n = 6) such as mixtard or only soluble had HbA1c 14%.